logo
Select company
Select metric
$ 7.99MWorking Capital
VS
Market
33
Sector
26
Industry
25
History
35
$ 0.8Close
$ 0.68 - $ 2.3 52-Week Range
Ticker Information

Ticker

LGVN

Company Name

LONGEVERON INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

LONGEVERON INC - Working Capital Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

LGVN - Working Capital Historical data
DateCurrent AssetsCurrent LiabilitiesWorking Capital
6/30/2025$ 11.27M$ 3.28M$ 7.99M
3/31/2025$ 15.28M$ 2.72M$ 12.55M
12/31/2024$ 19.62M$ 2.58M$ 17.04M
9/30/2024$ 23.77M$ 3.1M$ 20.67M
6/30/2024$ 13.41M$ 3.21M$ 10.2M
3/31/2024$ 3.76M$ 5.29M$ -1.54M
12/31/2023$ 5.85M$ 3.89M$ 1.96M
9/30/2023$ 5.04M$ 3.39M$ 1.65M
6/30/2023$ 10.29M$ 4.08M$ 6.21M
3/31/2023$ 14.87M$ 3.6M$ 11.28M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • LONGEVERON INC's latest trailing twelve months (TTM) Working Capital stands at $ -115.78K.
  • Over the past 5 years, LONGEVERON INC's average Working Capital has been $ 12.72M.
  • The median Working Capital for LONGEVERON INC during this period was $ 12.55M
  • LONGEVERON INC reached its highest Working Capital over the past 5 years at $ 32.67M.
  • The lowest Working Capital recorded by LONGEVERON INC in the same timeframe $ -1.98M

LONGEVERON INC's Working Capital vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Working Capital Benchmarks
CompanyWorking Capital
CYCN : CYCLERION THERAPEUTICS INC $ 3.22MTRAW : TRAWS PHARMA INC $ 8.02MLYRA : LYRA THERAPEUTICS INC $ 19.9MERNA : ERNEXA THERAPEUTICS INC $ 2.14MBRTX : BIORESTORATIVE THERAPIES INC $ 3.93MAPRE : APREA THERAPEUTICS INC $ 13.76MXBIO : XENETIC BIOSCIENCES INC $ 4.45MTXMD : THERAPEUTICSMD INC $ 8.8MLUCY : INNOVATIVE EYEWEAR INC $ 10.73MLEXX : LEXARIA BIOSCIENCE CORP $ 4.32M

Definition of Working Capital

[Calculation] The working capital represents the capital used in day-to-day operations. It is the difference between a company’s short-term assets [AssetsC] and current liabilities [LiabilitiesC].
AssetsC - LiabilitesC
(=) Working Capital
Working Capital for LONGEVERON INC is calculated as follows: AssetsC [ $ 2.37M ] - LiabilitesC [ $ 2.49M ]
(=) Working Capital [ $ -115.78K ]

LGVN - Working Capital, Last 5 years

$ -1.98M

Minimum

Dec 31, 2020

$ 32.67M

Maximum

Dec 31, 2021

$ 12.72M

Average

$ 12.55M

Median

Working Capital Benchmark Analysis

The chart above depicts the distribution of Working Capital for companies in the Total Stock Market. The average Working Capital of the companies is $ 96.1M with a standard deviation of $ 174.5M.
The following table provides additional summary stats:
Working Capital in the Market:
filtered constituents2.78K
min$ -468.61M
max$ 607.04M
average$ 96.1M
median$ 32.21M
std$ 174.5M